Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease-Reference-Cited by-同舟云学术

Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease

Published:2019-07-19 Issue:1 Volume:18 Page:
ISSN:1475-2840
Container-title:Cardiovascular Diabetology
language:en
Short-container-title:Cardiovasc Diabetol

Author:

Palanca Ana,Castelblanco Esmeralda,Betriu Àngels,Perpiñán Hèctor,Soldevila Berta,Valdivielso José Manuel,Bermúdez-Lopez Marcelino,Puig-Jové Carlos,Puig-Domingo Manel,Groop Per-Henrik,Fernández Elvira,Alonso Núria,Mauricio Didac^ORCID

Funder

Instituto de Salud Carlos III

European Foundation for the Study of Diabetes

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1186/s12933-019-0897-y.pdf

Reference50 articles.

1. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006;332:73–8.

2. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229–34.

3. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky MA, Hodgson JM, Kushner FG, Lauer MS, Shaw LJ, Smith SC Jr, Taylor AJ, Weintraub WS, Wenger NK, Jacobs AK, Smith SC Jr, Anderson JL, Albert N, Buller CE, Creager MA, Ettinger SM, Guyton RA, Halperin JL, Hochman JS, Kushner FG, Nishimura R, Ohman EM, Page RL, Stevenson WG, Tarkington LG, Yancy CW, American College of Cardiology Foundation and American Heart Association. ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2010;2010(56):e50–103.

4. Piepoli MF, Hoes AW, Agewall S. European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016;37:2291–3.

5. Evans JM, Wang J, Morris AD. Comparison of cardiovascular risk between individuals with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies. BMJ. 2002;324:939–42.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pentoxifylline ameliorates subclinical atherosclerosis progression in patients with type 2 diabetes and chronic kidney disease: a randomized pilot trial;Cardiovascular Diabetology;2024-08-24

2. Pentoxifylline Ameliorates Subclinical Atherosclerosis Progression in Patients with Type 2 Diabetes and Chronic Kidney Disease: A Randomized Pilot Trial;2024-07-03

3. Systemic immune-inflammation index mediates the association between metabolic dysfunction-associated fatty liver disease and sub-clinical carotid atherosclerosis: a mediation analysis;Frontiers in Endocrinology;2024-06-18

4. Mitochondrial DNA and Inflammation Are Associated with Cerebral Vessel Remodeling and Early Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus;Biomolecules;2024-04-19

5. Cardio‐renal‐metabolic disease in primary care setting;Diabetes/Metabolism Research and Reviews;2023-12-19